comprehensive -WSS

comprehensive

author：focus 2025-10-02 09:21:57 - browse：2

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： What affirmative action's end means to a medical student

hotspot

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

UpToDate has a racism problem: Dr. Stanley Goldfarb

Novo Nordisk obesity pill bests Wegovy in early trial

Hubble vs. James Webb telescope images: See the difference

RSV shot was 90% effective at preventing hospitalizations in kids

Amylyx ALS drug fails large clinical trial

focus

comprehensive

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Lupron, used to halt puberty in children, may cause lasting health problems

Activists slam private health insurers over coverage restrictions

Lupron, used to halt puberty in children, may cause lasting health problems

In age of alternative facts, a scholarly course on calling out crap

Use doctors trained outside the U.S. to ease the physician shortage

23andMe had bad news about my health. I wish a person had delivered it

Air quality improving but still lags in Black, Hispanic communities

Drug repurposing or repositioning? The language matters

Lupron, used to halt puberty in children, may cause lasting health problems

Wikipedia

Just how do doctors, lawmakers, and the public define abortion?

With psoriasis trial ahead, Alumis raises $259 million

Crowdfunding for unproven stem cell procedures spreads misinformation

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Hubble vs. James Webb telescope images: See the difference

knowledge

focus

hotspot

entertainment